603939 益丰药房
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)11.07315.38315.73913.83015.070
总资产报酬率 ROA (%)4.3256.2526.6265.4846.945
投入资产回报率 ROIC (%)5.2567.6117.9956.4695.589

边际利润分析
销售毛利率 (%)40.39238.20939.52940.34637.981
营业利润率 (%)9.2089.0979.4828.7368.623
息税前利润/营业总收入 (%)9.8879.4029.9689.4799.653
净利润/营业总收入 (%)6.9606.9997.1586.4646.386

收益指标分析
经营活动净收益/利润总额(%)95.37396.763100.03495.72296.011
价值变动净收益/利润总额(%)4.8612.0800.3662.5692.610
营业外收支净额/利润总额(%)-0.351-0.844-0.429-0.072-0.543

偿债能力分析
流动比率 (X)1.1941.0761.0951.1741.306
速动比率 (X)0.8770.7380.7210.7230.936
资产负债率 (%)59.94456.71756.65253.87963.049
带息债务/全部投入资本 (%)43.50739.31638.39433.575--
股东权益/带息债务 (%)105.527125.160129.685154.85991.106
股东权益/负债合计 (%)62.85771.62071.77181.42955.452
利息保障倍数 (X)13.90524.64218.91312.6478.966

营运能力分析
应收账款周转天数 (天)29.92831.73326.43822.3990.000
存货周转天数 (天)101.35095.72299.615102.6270.000